iBio (IBIO) Interest Expenses (2010 - 2026)
iBio (IBIO) posted quarterly Interest Expenses of $141000.0 for Q1 2026, little changed year-over-year from $141000.0 in Q1 2025, and little changed quarter-over-quarter from $141000.0 in Q4 2025.
iBio (IBIO) Interest Expenses (2010 - 2026) Analysis & Trends
iBio (IBIO) has reported Interest Expenses for 17 consecutive years, with $141000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses changed 0.0% year-over-year to $141000.0; the TTM figure through Mar 2026 stood at $37000.0 (down 36.21% YoY), while the FY2025 annual figure was $63.4 million, up 15.57% from the prior year.
- Interest Expenses was little changed at $141000.0 in Q1 2026 per IBIO's latest filing, from $141000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $3.6 million in Q4 2022 and bottomed at -$281000.0 in Q2 2024.
- Historically, Interest Expenses has averaged $606882.4 across 5 years, with a median of $141000.0 in 2024.
- Annual changes were most pronounced in 2023 — Interest Expenses jumped 1770.0% — and 2024, when it plunged 133.65%.
- iBio's Interest Expenses stood at $3.6 million in 2022, then plunged by 91.32% to $316000.0 in 2023, then plunged by 55.38% to $141000.0 in 2024, then changed by 0.0% to $141000.0 in 2025, then changed by 0.0% to $141000.0 in 2026.
- Business Quant data shows IBIO's Interest Expenses at $141000.0 in Q1 2026, $141000.0 in Q4 2025, and $36000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 141,000.00 |
| Mar 31, 2026 | 141,000.00 |
| Dec 31, 2025 | 141,000.00 |
| Dec 31, 2025 | 141,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | -281,000.00 |
| Jun 30, 2025 | -281,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Mar 31, 2025 | 141,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Dec 31, 2024 | 141,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | -281,000.00 |
| Jun 30, 2024 | -281,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Dec 31, 2023 | 316,000.00 |